Crossmark

Suitability of prolonged meloxicam treatment in mice seems limited due to unfavorable pharmacokinetics, side effects, and impact on home-cage behaviors

Crossref DOI link: https://doi.org/10.1038/s41598-025-25180-4

Published Online: 2025-11-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Glasenapp, Aylina

Bankstahl, Jens P.

Bähre, Heike

Hauser, Jana

Parmar, Amisha R.

Kozlov, Andrey V.

Glage, Silke

Palme, Rupert

Bankstahl, Marion
Funding

Funding for this research was provided by:

Medizinische Hochschule Hannover (MHH)
License Information

Text and Data Mining valid from 2025-11-07

Version of Record valid from 2025-11-07
More Information

Article History

Received: 17 June 2025

Accepted: 17 October 2025

First Online: 7 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below